Biosimilars in treatment of multiple sclerosis in Iran
Systematic shortlisting of candidate molecules and biosimilar/biobetter product development: An undergraduate research effort
Balram Pani, Pooja Gupta, Ranjeet S Thakur, Avneesh Mittal, Purnima Anand, Deepika Bhaskar and Uma Chaudhry
Emerging biosimilars in the USA â Quo vadis?
Brexit and biosimilars
Evolution of structure-function paradigm in biopharmaceutics based on global regulatory needs
Using IPRs in the biosimilars context
nSMOL-Development of novel LCMS bioanalytical approach by Fab-selective quantitation of monoclonal antibodies using nano-surface and molecular orientation limited proteolysis